These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32669514)

  • 21. Probable sarcopenia: associations with common geriatric syndromes and comorbidities in Turkish geriatric patients from a university hospital.
    Erbas Sacar D; Kılıc C; Oren MM; Erdogan T; Ozkok S; Ozer Aydın C; Catikkas NM; Karan MA; Bahat G
    Eur Geriatr Med; 2022 Dec; 13(6):1299-1308. PubMed ID: 36029439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
    Okuyama M; Nakahara K; Iwakura N; Hasegawa T; Oyama M; Inoue A; Ishizu H; Satoh H; Fujiwara Y
    Digestion; 2017; 95(4):281-287. PubMed ID: 28501868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher Frequency of Reflux Symptoms and Acid-Related Dyspepsia in Women than Men Regardless of Endoscopic Esophagitis: Analysis of 3,505 Japanese Subjects Undergoing Medical Health Checkups.
    Takeshita E; Sakata Y; Hara M; Akutagawa K; Sakata N; Endo H; Ohyama T; Matsunaga K; Yoshioka T; Kawakubo H; Tanaka Y; Shirai S; Ito Y; Tsuruoka N; Iwakiri R; Kusano M; Fujimoto K
    Digestion; 2016; 93(4):266-71. PubMed ID: 27160990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoscopic grading of gastroesophageal flap valve helps predict proton pump inhibitor response in patients with gastroesophageal reflux disease.
    Cheong JH; Kim GH; Lee BE; Choi MK; Moon JY; Ryu DY; Kim DU; Song GA
    Scand J Gastroenterol; 2011 Jul; 46(7-8):789-96. PubMed ID: 21615222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
    Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
    J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone health assessment in older people with or without muscle health impairment.
    Locquet M; Beaudart C; Bruyère O; Kanis JA; Delandsheere L; Reginster JY
    Osteoporos Int; 2018 May; 29(5):1057-1067. PubMed ID: 29445830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson's Disease: A Cross-Sectional Study.
    Peball M; Mahlknecht P; Werkmann M; Marini K; Murr F; Herzmann H; Stockner H; de Marzi R; Heim B; Djamshidian A; Willeit P; Willeit J; Kiechl S; Valent D; Krismer F; Wenning GK; Nocker M; Mair K; Poewe W; Seppi K
    Gerontology; 2019; 65(3):216-228. PubMed ID: 30199864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex effects on the association between sarcopenia EWGSOP and osteoporosis in outpatient older adults: data from the SARCOS study.
    Frisoli A; Martin FG; Carvalho ACC; Borges J; Paes AT; Ingham SJM
    Arch Endocrinol Metab; 2018; 62(6):615-622. PubMed ID: 30624502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
    Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?
    Asaoka D; Nagahara A; Shimada Y; Matsumoto K; Ueyama H; Matsumoto K; Nakagawa Y; Takeda T; Tanaka I; Sasaki H; Osada T; Hojo M; Watanabe S
    Ther Clin Risk Manag; 2015; 11():381-91. PubMed ID: 25834453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
    Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
    Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: a retrospective study of 932 patients.
    Schatz RA; Zhang Q; Lodhia N; Shuster J; Toskes PP; Moshiree B
    World J Gastroenterol; 2015 Apr; 21(15):4574-82. PubMed ID: 25914466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.
    Chen CH; Lin CL; Kao CH
    Osteoporos Int; 2016 Jun; 27(6):2117-26. PubMed ID: 26860609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.
    Matsuhashi N; Kudo M; Yoshida N; Murakami K; Kato M; Sanuki T; Oshio A; Joh T; Higuchi K; Haruma K; Nakada K
    J Gastroenterol; 2015 Dec; 50(12):1173-83. PubMed ID: 25851931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.
    Patel DA; Sharda R; Choksi YA; Slaughter JC; Higginbotham T; Garrett CG; Francis DO; Ravi K; Hasak S; Katzka D; Gyawali CP; Vaezi MF
    Gastroenterology; 2018 Dec; 155(6):1729-1740.e1. PubMed ID: 30170117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of diagnosing frailty and sarcopenia in vascular surgery practice.
    Ghaffarian AA; Foss WT; Donald G; Kraiss LW; Sarfati M; Griffin CL; Smith BK; Brooke BS
    J Vasc Surg; 2019 Sep; 70(3):892-900. PubMed ID: 30850295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sarcopenia increases risk of long-term mortality in elderly patients undergoing emergency abdominal surgery.
    Rangel EL; Rios-Diaz AJ; Uyeda JW; Castillo-Angeles M; Cooper Z; Olufajo OA; Salim A; Sodickson AD
    J Trauma Acute Care Surg; 2017 Dec; 83(6):1179-1186. PubMed ID: 28777289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential association of frailty with cognitive decline and sarcopenia in community-dwelling older adults.
    Nishiguchi S; Yamada M; Fukutani N; Adachi D; Tashiro Y; Hotta T; Morino S; Shirooka H; Nozaki Y; Hirata H; Yamaguchi M; Arai H; Tsuboyama T; Aoyama T
    J Am Med Dir Assoc; 2015 Feb; 16(2):120-4. PubMed ID: 25244957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
    Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
    Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between osteosarcopenia and cognitive frailty in older outpatients visiting a frailty clinic.
    Inoue T; Shimizu A; Satake S; Matsui Y; Ueshima J; Murotani K; Arai H; Maeda K
    Arch Gerontol Geriatr; 2022; 98():104530. PubMed ID: 34562795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.